Verderame M F, Varmus H E
Department of Microbiology and Immunology, College of Medicine, Pennsylvania State University, Hershey 17033.
Oncogene. 1994 Jan;9(1):175-82.
We have identified 11 novel point mutations that abolish the transforming capacity of the oncogene v-src. These transformation-defective alleles were originally identified in morphologically flat subclones of rat cells transformed by wild type v-src. Nine of the mutations affect amino acid residues that are highly conserved in the catalytic domain of pp60v-src and completely abolish kinase activity. The other 2 mutations alter conserved residues in the SH2 domain (Phe-172 replaced with Val in one case [F172V] and Leu-186 replaced with Phe in the other [L186F]), drastically reducing, but not eliminating, kinase activity. The enzymatic and transforming functions of one of the SH2 mutants, L186F are host dependent; the mutant protein is active in chicken cells, but inactive in rat cells, as previously observed for some other SH2 mutants. These results are interpreted in relation to the recently described three-dimensional structures of SH2 domains and of the catalytic domain of a protein kinase. In addition, they support a role for the SH2 domain in the regulation of kinase activity.
我们已经鉴定出11种新的点突变,这些突变消除了癌基因v-src的转化能力。这些转化缺陷型等位基因最初是在由野生型v-src转化的大鼠细胞的形态扁平亚克隆中鉴定出来的。其中9个突变影响pp60v-src催化结构域中高度保守的氨基酸残基,并完全消除激酶活性。另外2个突变改变了SH2结构域中的保守残基(一种情况是苯丙氨酸-172被缬氨酸取代[F172V],另一种情况是亮氨酸-186被苯丙氨酸取代[L186F]),大幅降低但并未消除激酶活性。其中一个SH2突变体L186F的酶促和转化功能依赖于宿主;如之前在其他一些SH2突变体中所观察到的,该突变蛋白在鸡细胞中具有活性,但在大鼠细胞中无活性。这些结果结合最近描述的SH2结构域和蛋白激酶催化结构域的三维结构进行了解释。此外,它们支持SH2结构域在激酶活性调节中的作用。